Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

ROBERT C HOOD

Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism

NPI
1053321539
CMS profile
320132
Location
BEAUMONT, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2019 · Entire year

$364,763.75

657 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2019 · entire year · sorted by reported total

By paying entity

PY2019 · entire year · sorted by reported total

Page 3 of 14; records 101–150 of 657 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

ROBERT C HOOD

NPI 1053321539 · CMS profile ID 320132

Allopathic & Osteopathic Physicians / Internal Medicine / Endocrinology, Diabetes & Metabolism

BEAUMONT, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 14; records 101–150 of 657 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1053321539?year=2019&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
ROBERT C HOOD, NPI 1053321539, CMS profile ID 320132. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 14; records 101–150 of 657 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1053321539?year=2019&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
APA 7
IndustryPayments. (2026). ROBERT C HOOD, NPI 1053321539, CMS profile ID 320132. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 14; records 101–150 of 657 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1053321539?year=2019&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
Bluebook
ROBERT C HOOD, NPI 1053321539, CMS profile ID 320132, IndustryPayments, General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 14; records 101–150 of 657 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e. https://industrypayments.org/provider/npi-1053321539?year=2019&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2019

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2019 · Physicians and non-physician practitioners · CMS publication 2026-06-30

657 matching records · $364,763.75 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 657 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–150 of 657.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Amgen Inc. $865.1510/24/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 662938255 CMS
Amgen Inc. $99.5510/24/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 662938267 CMS
Amgen Inc. $13.5410/24/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 662938785 CMS
Janssen Pharmaceuticals, Inc $2,750.0010/23/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658734313 CMS
Janssen Pharmaceuticals, Inc $97.8310/23/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658734317 CMS
Amgen Inc. $110.8710/22/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 662938205 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $14.9410/22/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 700451481 CMS
IBSA Pharma Inc. $13.1310/21/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 682228379 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $354.3410/18/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 700451379 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $18.9010/18/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 700451395 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $2,715.7610/18/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 700451397 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $116.7710/18/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 700451497 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $26.3210/18/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 700451499 CMS
Janssen Pharmaceuticals, Inc $15.9610/18/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658734305 CMS
Amgen Inc. $2,200.0010/16/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 662938219 CMS
Amgen Inc. $734.0010/16/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 662938227 CMS
Amgen Inc. $148.4010/16/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 662938251 CMS
Amgen Inc. $136.7010/16/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 662938323 CMS
Corcept Therapeutics $11.2810/16/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 695511709 CMS
Novo Nordisk Inc $688.5010/16/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 750697627 CMS
Abbott Laboratories $24.3010/15/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 664406003 CMS
Amgen Inc. $19.4010/15/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 662938861 CMS
Amgen Inc. $18.4410/14/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 662938233 CMS
Amgen Inc. $40.6710/14/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 662938239 CMS
Amgen Inc. $196.5310/12/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 662938261 CMS
Amgen Inc. $21.2510/11/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 662938743 CMS
Amgen Inc. $633.9010/11/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 662938747 CMS
Amgen Inc. $65.2110/10/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 662938209 CMS
Amgen Inc. $2,200.0010/09/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 662938215 CMS
Janssen Pharmaceuticals, Inc $692.0210/09/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658734293 CMS
Janssen Pharmaceuticals, Inc $119.1110/09/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658734297 CMS
Regeneron Healthcare Solutions, Inc. $15.0010/09/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 673395151 CMS
Lilly USA, LLC $26.6310/08/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658115533 CMS
Shire North American Group Inc $18.8310/08/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 637842571 CMS
Amgen Inc. $545.2010/07/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 662938795 CMS
Amgen Inc. $270.3210/05/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 662938257 CMS
Amgen Inc. $15.4610/05/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 662938264 CMS
Amgen Inc. $75.2210/03/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 662938213 CMS
Lilly USA, LLC $27.3310/03/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658095157 CMS
Lilly USA, LLC $800.0010/03/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658115531 CMS
Lilly USA, LLC $1,000.0010/03/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658118737 CMS
Janssen Pharmaceuticals, Inc $203.2410/02/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658734286 CMS
Lilly USA, LLC $1,400.0010/02/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658105337 CMS
Lilly USA, LLC $1,600.0010/02/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658108741 CMS
Amgen Inc. $19.4009/30/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 662938117 CMS
Lilly USA, LLC $20.0909/28/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658115535 CMS
Lilly USA, LLC $618.9009/27/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658095135 CMS
Lilly USA, LLC $481.9209/26/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658095131 CMS
Lilly USA, LLC $232.1909/26/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658112163 CMS
Lilly USA, LLC $16.0909/26/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658115521 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $364,763.75 657
PY2020 $173,093.42 350
PY2021 $139,775.87 267
PY2022 $217,422.27 351
PY2023 $128,874.84 297
PY2024 $132,742.10 316
PY2025 $140,108.09 246

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2023 Recipient $1,070.02 2
PY2023 Principal investigator $9,718.40 19
PY2022 Principal investigator $26,735.00 16
PY2021 Principal investigator $42,919.78 23
PY2020 Recipient $1,200.00 1
PY2020 Principal investigator $21,313.76 20
PY2019 Principal investigator $81,120.96 19

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

21 records in PY2023

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Recipient Eli Lilly and Company $535.01 09/19/2023 Covered Recipient Physician A PHASE 3 RANDOMIZED OPEN-LABEL STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF ONCE DAILY ORAL LY3502970 COMPARED WITH ORAL SEMAGLUTIDE IN ADULT PARTICIPANTS WITH TYPE 2 DIABETES AND INADEQUATE GLYCEMIC CONTROL WITH METFORMIN (ACHIEVE-3) No dispute reported 06/30/2026 1038056207
Principal investigator 1 Eli Lilly and Company $1,061.70 09/11/2023 Non-covered Recipient Entity
DISCOVERESEARCH INC
A PHASE 3 RANDOMIZED OPEN-LABEL STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF ONCE DAILY ORAL LY3502970 COMPARED WITH ORAL SEMAGLUTIDE IN ADULT PARTICIPANTS WITH TYPE 2 DIABETES AND INADEQUATE GLYCEMIC CONTROL WITH METFORMIN (ACHIEVE-3) No dispute reported 06/30/2026 1038086605
Recipient Eli Lilly and Company $535.01 08/31/2023 Covered Recipient Physician A STUDY OF ORFORGLIPRON (LY3502970) IN ADULT PARTICIPANTS WITH TYPE 2 DIABETES AND INADEQUATE GLYCEMIC CONTROL WITH DIET AND EXERCISE ALONE (ACHIEVE-1) No dispute reported 06/30/2026 1038057439
Principal investigator 1 Eli Lilly and Company $265.45 08/31/2023 Non-covered Recipient Entity
DISCOVERESEARCH INC
A STUDY OF ORFORGLIPRON (LY3502970) IN ADULT PARTICIPANTS WITH TYPE 2 DIABETES AND INADEQUATE GLYCEMIC CONTROL WITH DIET AND EXERCISE ALONE (ACHIEVE-1) No dispute reported 06/30/2026 1038091733
Principal investigator 1 ABBVIE INC. $2,000.00 05/11/2023 Non-covered Recipient Entity
DISCOVER RESEARCH INC
A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascular Events (MACE) and Efficacy Measures in Hypogonadal Men No dispute reported 06/30/2026 998383043
Principal investigator 1 ABBVIE INC. $93.75 02/16/2023 Non-covered Recipient Entity
DISCOVER RESEARCH INC
A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascular Events (MACE) and Efficacy Measures in Hypogonadal Men No dispute reported 06/30/2026 998371031
Principal investigator 1 ABBVIE INC. $93.75 02/16/2023 Non-covered Recipient Entity
DISCOVER RESEARCH INC
A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascular Events (MACE) and Efficacy Measures in Hypogonadal Men No dispute reported 06/30/2026 998371069
Principal investigator 1 ABBVIE INC. $64.00 02/14/2023 Non-covered Recipient Entity
DISCOVER RESEARCH INC
A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascular Events (MACE) and Efficacy Measures in Hypogonadal Men No dispute reported 06/30/2026 998370579
Principal investigator 1 ABBVIE INC. $192.00 02/14/2023 Non-covered Recipient Entity
DISCOVER RESEARCH INC
A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascular Events (MACE) and Efficacy Measures in Hypogonadal Men No dispute reported 06/30/2026 998370581
Principal investigator 1 ABBVIE INC. $192.00 02/14/2023 Non-covered Recipient Entity
DISCOVER RESEARCH INC
A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascular Events (MACE) and Efficacy Measures in Hypogonadal Men No dispute reported 06/30/2026 998370583
Principal investigator 1 ABBVIE INC. $192.00 02/14/2023 Non-covered Recipient Entity
DISCOVER RESEARCH INC
A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascular Events (MACE) and Efficacy Measures in Hypogonadal Men No dispute reported 06/30/2026 998370585
Principal investigator 1 ABBVIE INC. $64.00 02/14/2023 Non-covered Recipient Entity
DISCOVER RESEARCH INC
A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascular Events (MACE) and Efficacy Measures in Hypogonadal Men No dispute reported 06/30/2026 998370589
Principal investigator 1 ABBVIE INC. $64.00 02/14/2023 Non-covered Recipient Entity
DISCOVER RESEARCH INC
A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascular Events (MACE) and Efficacy Measures in Hypogonadal Men No dispute reported 06/30/2026 998370591
Principal investigator 1 ABBVIE INC. $64.00 02/14/2023 Non-covered Recipient Entity
DISCOVER RESEARCH INC
A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascular Events (MACE) and Efficacy Measures in Hypogonadal Men No dispute reported 06/30/2026 998370611
Principal investigator 1 ABBVIE INC. $128.00 02/14/2023 Non-covered Recipient Entity
DISCOVER RESEARCH INC
A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascular Events (MACE) and Efficacy Measures in Hypogonadal Men No dispute reported 06/30/2026 998370613
Principal investigator 1 ABBVIE INC. $187.50 02/07/2023 Non-covered Recipient Entity
DISCOVER RESEARCH INC
A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascular Events (MACE) and Efficacy Measures in Hypogonadal Men No dispute reported 06/30/2026 998368867
Principal investigator 1 ABBVIE INC. $187.50 02/07/2023 Non-covered Recipient Entity
DISCOVER RESEARCH INC
A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascular Events (MACE) and Efficacy Measures in Hypogonadal Men No dispute reported 06/30/2026 998368869
Principal investigator 1 ABBVIE INC. $281.25 02/07/2023 Non-covered Recipient Entity
DISCOVER RESEARCH INC
A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascular Events (MACE) and Efficacy Measures in Hypogonadal Men No dispute reported 06/30/2026 998368879
Principal investigator 1 ABBVIE INC. $187.50 02/07/2023 Non-covered Recipient Entity
DISCOVER RESEARCH INC
A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascular Events (MACE) and Efficacy Measures in Hypogonadal Men No dispute reported 06/30/2026 998368881
Principal investigator 1 ABBVIE INC. $1,000.00 02/02/2023 Non-covered Recipient Entity
DISCOVER RESEARCH INC
A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascular Events (MACE) and Efficacy Measures in Hypogonadal Men No dispute reported 06/30/2026 998368541
Principal investigator 1 ABBVIE INC. $3,400.00 02/02/2023 Non-covered Recipient Entity
DISCOVER RESEARCH INC
A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascular Events (MACE) and Efficacy Measures in Hypogonadal Men No dispute reported 06/30/2026 998368669